- Home
- CVAC
CVAC
CureVac N.V.
as 07-26-2024 4:00pm EST
CureVac is a biopharmaceutical company headquartered in Germany that is developing vaccines and therapies using messenger ribonucleic acid, or mRNA. The company was founded in 2000 and had its initial public offering in August 2020. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and Covid vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.
| Founded: | 2000 | Country: | Germany |
| Employees: | N/A | City: | N/A |
| Market Cap: | 807.5M | IPO Year: | 2020 |
| Target Price: | $10.00 | AVG Volume (30 days): | 1.3M |
| Analyst Decision: | Hold | Number of Analysts: | 4 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.32 | EPS Growth: | N/A |
| 52 Week Low/High: | $2.21 - $10.14 | Next Earning Date: | 08-15-2024 |
| Revenue: | $64,132,609 | Revenue Growth: | 17.59% |
| Revenue Growth (this year): | -4.51% | Revenue Growth (next year): | 71.71% |
Latest CureVac N.V. News
CVAC Breaking Stock News: Dive into CVAC Ticker-Specific Updates for Smart Investing
Zacks
11 days ago
CureVac (CVAC) Upgraded to Buy: What Does It Mean for the Stock?
MT Newswires
16 days ago
CureVac Provides Trial Dates for Patent Litigation Against Pfizer, BioNTech
ACCESSWIRE
16 days ago
CureVac Provides Update on Trial Dates for Patent Litigation Across Multiple Geographies Against Pfizer/BioNTech
Simply Wall St.
21 days ago
An Intrinsic Calculation For CureVac N.V. (NASDAQ:CVAC) Suggests It's 47% Undervalued
Morningstar Research
22 days ago
Analyst Report: CureVac N.V.
Zacks
22 days ago
GSK Buys Flu, COVID mRNA Jab Rights From Partner CureVac
Zacks
23 days ago
Biotech Stock Roundup: GSK, CVAC Revise Agreement, Updates From MRNA, RNAC & More
Pharmaceutical Technology
23 days ago
CureVac announces restructuring to focus on mRNA projects
Compare CVAC vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "CVAC CureVac N.V. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.